Clinical Trial Update: Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing standard versus reduced-intensity conditioning in patients with Acute Myeloid Leukemia in first remission was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University Hospital Carl Gustav Carus | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED